If any of the event occurred as agreed between the parties, the agreement will be terminated and all rights and obligation to each party will cease. Completion shall take place within five business days from the date of fulfillment of all conditions. The transaction is subject to certain conditions including no event or circumstances occurring from date of agreement to completion date, approval from shareholders of Malaysian Genomics Resource Centre Berhad and consent from respective lenders including but not limited to facilities provided by CIMB Islamic Bank Berhad and RHB Islamic Bank Berhad and approvals or consents of any other relevant authorities if required. For the year ended June 30, 2019, MPath Sdn Bhd has reported revenues of MYR 27.46 million, profit before tax of MYR 0.56 million, profit after tax of MYR 0.23 million and shareholders fund of MYR 20.5 million. Upon completion, MPath Sdn Bhd will cease to be subsidiary of Malaysian Genomics Resource Centre Berhad. Bhd intends to finance the transaction through bank borrowings. As per the terms, consideration will be payable in cash. entered into an agreement to acquire MPath Sdn Bhd from Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) for MYR 42 million on October 11, 2019.

Sdn pathology